- Home
- OGS vs OGN Comparison
OGS vs OGN Comparison
Compare OGS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGS
- OGN
- Stock Information
- Founded
- OGS 1906
- OGN 1923
- Country
- OGS United States
- OGN United States
- Employees
- OGS N/A
- OGN N/A
- Industry
- OGS Oil/Gas Transmission
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- OGS Utilities
- OGN Health Care
- Exchange
- OGS Nasdaq
- OGN Nasdaq
- Market Cap
- OGS 4.5B
- OGN 4.0B
- IPO Year
- OGS N/A
- OGN N/A
- Fundamental
- Price
- OGS $76.33
- OGN $14.45
- Analyst Decision
- OGS Hold
- OGN Hold
- Analyst Count
- OGS 7
- OGN 5
- Target Price
- OGS $71.79
- OGN $20.80
- AVG Volume (30 Days)
- OGS 381.0K
- OGN 4.0M
- Earning Date
- OGS 05-05-2025
- OGN 05-01-2025
- Dividend Yield
- OGS 3.50%
- OGN 7.75%
- EPS Growth
- OGS N/A
- OGN N/A
- EPS
- OGS 3.91
- OGN 3.33
- Revenue
- OGS $2,083,558,000.00
- OGN $6,403,000,000.00
- Revenue This Year
- OGS $26.18
- OGN N/A
- Revenue Next Year
- OGS N/A
- OGN $0.71
- P/E Ratio
- OGS $19.60
- OGN $4.34
- Revenue Growth
- OGS N/A
- OGN 2.23
- 52 Week Low
- OGS $58.31
- OGN $13.87
- 52 Week High
- OGS $78.89
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- OGS 61.93
- OGN 43.47
- Support Level
- OGS $74.71
- OGN $13.90
- Resistance Level
- OGS $77.00
- OGN $14.94
- Average True Range (ATR)
- OGS 1.29
- OGN 0.52
- MACD
- OGS 0.23
- OGN -0.08
- Stochastic Oscillator
- OGS 83.98
- OGN 27.85
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.